Latest Articles
I waited 10 months for a referral before being told 'it's stage 4 cancer' - Kent Live
I waited 10 months for a referral before being told 'it's stage 4 cancer' Kent Live
Published: Feb. 19, 2026, 10:19 a.m.
Woman diagnosed with stage 4 cancer at 27 after 10-month hospital referral wait - The Mirror
Woman diagnosed with stage 4 cancer at 27 after 10-month hospital referral wait The Mirror
Published: Feb. 19, 2026, 8:51 a.m.
‘I waited 10 months for a hospital referral for suspected endometriosis – then I got my stage 4 cancer diagnosis at 27’ - Ireland Live
‘I waited 10 months for a hospital referral for suspected endometriosis – then I got my stage 4 cancer diagnosis at 27’ Ireland Live
Published: Feb. 19, 2026, 6:58 a.m.
‘I waited 10 months for a hospital referral for suspected endometriosis – then I got my stage 4 cancer diagnosis at 27’ - Yahoo Life UK
‘I waited 10 months for a hospital referral for suspected endometriosis – then I got my stage 4 cancer diagnosis at 27’ Yahoo Life UK
Published: Feb. 19, 2026, 6:30 a.m.
Aprea reports second partial response in endometrial cancer trial By Investing.com - Investing.com South Africa
Aprea reports second partial response in endometrial cancer trial By Investing.com Investing.com South Africa
Published: Feb. 19, 2026, 12:54 a.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com Nigeria
Aprea reports second partial response in endometrial cancer trial Investing.com Nigeria
Published: Feb. 18, 2026, 11:46 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics, Raises $200M to Advance Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer - Femtech Insider
Sensei Biotherapeutics Acquires Faeth Therapeutics in $200M Deal, Advancing Multi-Node Cancer Therapy for Endometrial and Breast Cancer Femtech Insider
Published: Feb. 18, 2026, 3:28 p.m.
Aprea reports second partial response in endometrial cancer trial - Investing.com
Aprea reports second partial response in endometrial cancer trial Investing.com
Published: Feb. 18, 2026, 1:42 p.m.
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk - European Medical Journal
GLP 1 Receptor Agonists Reduce Endometrial Cancer Risk European Medical Journal
Published: Feb. 18, 2026, noon
Link copied to clipboard!